National Institutes of Health: all 11,571 studies

Page 109 of 116. Open to participants first (945), then studies with results posted, then the rest; newest registration first within each.

• A Study to Evaluate the Effects of Anti-HIV Drugs in HIV-Positive Patients Who Also Have Hepatitis C InfectionCompletedNCT00001117
• A Study to Evaluate the Ability of TNFR:Fc to Decrease the Amount of IL-6 (Interleukin-6) and TNF-alpha (Tumor Necrosis Factor) in HIV-Infected PatientsCompletedNCT00001116Not applicable
• The Effect of Acyclovir Treatment of the Herpes Simplex Virus (HSV) Infection on HIV Levels in the BloodCompletedNCT00001115Not applicable
• The Safety and Effectiveness of Interferon Alfa-2B Plus Didanosine in Patients With Kaposi's SarcomaCompletedNCT00001114Phase 2
• A Study of AZT Plus Human Interferon Alpha in the Treatment of AIDS-Related Kaposi's SarcomaCompletedNCT00001113Phase 1
• The Safety and Effectiveness of Injections of Human Recombinant Interferon-gamma in Patients With AIDS Who Have Taken ZidovudineCompletedNCT00001112Phase 1
• A Study of Nevirapine Used Alone or in Combination With AZT in HIV-1-Infected ChildrenCompletedNCT00001111Not applicable
• Effect of Anti-HIV Therapy (HAART) on HIV Levels in the Lungs and on Lung Cell Inflammation in HIV-Infected PatientsCompletedNCT00001110Not applicable
• A Blood Test to Look at Cells of the Immune System in Healthy ChildrenCompletedNCT00001109
• A Study of the Safety and Effectiveness of Treating Advanced AIDS Patients Between Ages 4 and 22 With 7 Drugs, Some at Higher Than Usual DosesCompletedNCT00001108Phase 1
• Comparison of Two Treatments to Prevent Invasive Fungal Infections in Patients Who Have Received Liver TransplantsCompletedNCT00001107Phase 4
• A Study of Zidovudine in HIV-Infected Pregnant Women and Their ChildrenCompletedNCT00001106Phase 1
• The Safety and Effectiveness of Human Monoclonal Antibody, F105, in the Treatment of HIVCompletedNCT00001105Phase 1
• A Study of Zidovudine in HIV-Infected Patients Who Have HemophiliaCompletedNCT00001104Phase 3
• HIV Levels in Cerebrospinal Fluid and Brain Function in Patients Receiving Anti-HIV DrugsCompletedNCT00001103
• The Effect of Anti-HIV Therapy on Fat Metabolism in HIV-Positive PatientsCompletedNCT00001102
• A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seropositive Chronic Lyme DiseaseCompletedNCT00001101Phase 3
• A Phase III Study to Evaluate the Safety and Efficacy of Ganciclovir (Dihydroxypropoxymethyl Guanine [DHPG]) Treatment of Symptomatic Central Nervous System (CNS) Congenital Cytomegalovirus (CMV) Infections.CompletedNCT00001100Phase 3
• Long-Term Effects of HAART in Youth With Stronger Immune Systems Versus Youth With Weaker Immune SystemsCompletedNCT00001097
• A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 MN rsgp120 and Bivalent AIDSVAX B/E (HIV-1 MN rgp120/A244 rgp120) in Combination With QS-21 With or Without Alum in Healthy HIV-1 Uninfected AdultsCompletedNCT00001096Phase 1
• A Study of Three Anti-HIV Drug Combinations in Patients Who Have Taken AmprenavirCompletedNCT00001095Phase 2
• A Comparison of Nelfinavir Plus Saquinavir Plus Delavirdine or 3TC/ZDV Versus Nelfinavir Plus 3TC/ZDV in HIV-Infected PatientsWithdrawnNCT00001094Phase 2
• Outcomes of Anti-HIV Therapy During Early HIV InfectionCompletedNCT00001093
• The Biology of HIV TransmissionCompletedNCT00001092
• Safety and Effectiveness of Four Anti-HIV Drug Combinations in HIV-Infected Children and TeensCompletedNCT00001091Phase 1
• A Multicenter, Randomized, Placebo-Controlled, Double-Blinded, Phase I Trial to Evaluate the Safety and Immunogenicity of Live Recombinant Canarypox ALVAC-HIV vCP205 Combined With GM-CSF in Healthy, HIV-1 Uninfected VolunteersCompletedNCT00001090Phase 1
• A Study of HIV and Cytomegalovirus (CMV) in HIV-Infected PatientsCompletedNCT00001089
• A Phase I Safety and Immunogenicity Trial of the Facilitated HIV-1 Gag-Pol DNA Vaccine (APL-400-047, Apollon, Inc.) Given Intramuscularly by Needle and Syringe or Biojector 2000 Needle-Free Jet Injection System in HIV-1 Uninfected Adult VolunteersCompletedNCT00001088Phase 1
• The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV DrugsCompletedNCT00001087Phase 2
• A Study of Abacavir Plus Indinavir Sulfate Plus Efavirenz in HIV-Infected PatientsCompletedNCT00001086Phase 2
• A Study of 141W94 Used Alone or in Combination With Zidovudine Plus 3TC in HIV-Infected PatientsCompletedNCT00001085Phase 2
• A Study of Three Treatment Combinations Using Zidovudine Plus Lamivudine Plus Indinavir in HIV-Infected PatientsCompletedNCT00001084Phase 2
• Comparison of New Anti-HIV Drug Combinations in HIV-Infected Children Who Have Taken Anti-HIV DrugsCompletedNCT00001083Phase 2
• The Safety and Effectiveness of Adefovir Dipivoxil in the Treatment of HIV-Infected PatientsCompletedNCT00001082Phase 3
• A Study of Nitazoxanide in Patients With AIDS and Diarrhea Caused by CryptosporidiumCompletedNCT00001081Phase 2
• Effect of Vaccination on Turnover of Lamivudine (3TC) Sensitive and Resistant Virus Populations in HIV-1-Infected IndividualsWithdrawnNCT00001080Not applicable
• A Study of Megestrol Acetate Alone or in Combination With Testosterone Enanthate Drug in the Treatment of HIV-Associated Weight LossCompletedNCT00001079Phase 2
• A Study on the Rate of Opportunistic (AIDS-Related) Infections Among HIV-Positive Children Who Have Stopped Taking Their OI Preventive MedicationsCompletedNCT00001078Not applicable
• A Comparison of Two Caloric Supplements in the Prevention of Weight Loss in Patients With AIDS Who Take Daily Multivitamin and Mineral SupplementsCompletedNCT00001077
• A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) and HIV-1 SF-2 rgp120 in HIV-1 Uninfected Volunteers to Evaluate Accelerated Vaccine SchedulesCompletedNCT00001076Phase 1
• The Effectiveness of Ritonavir Plus Zidovudine Plus Lamivudine in HIV-Infected PatientsCompletedNCT00001075Not applicable
• The Safety and Effectiveness of Hydroxyurea and ddI Used Individually or Together in HIV-Infected PatientsCompletedNCT00001074Phase 1
• Safety and Effectiveness of Giving Isotretinoin to HIV-Infected Women to Treat Cervical TumorsCompletedNCT00001073Phase 3
• A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP300 and HIV-1 SF-2 rgp120 in HIV-1 Uninfected Adult VolunteersCompletedNCT00001072Phase 1
• A Study of Stem Cells and FilgrastimCompletedNCT00001071Not applicable
• The Safety and Effectiveness of Different Doses of Vitamin C in HIV-Infected PatientsWithdrawnNCT00001070Not applicable
• A Study of Two Methods of Determining When to Begin or Change Anti-HIV TreatmentTerminatedNCT00001069
• A Study of Disease Progression and Anti-HIV TreatmentsCompletedNCT00001068Phase 2
• The Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Never Used Anti-HIV DrugsCompletedNCT00001067Phase 2
• A Comparison of Zidovudine Plus Lamivudine Versus ddI Used Alone or in Combination With Zidovudine in HIV-1 Infected ChildrenCompletedNCT00001066Phase 2
• A Study of Amphotericin B in the Treatment of Fungal Infections of the Mouth in HIV-Infected Patients Who Have Not Had Success With FluconazoleCompletedNCT00001065Phase 2
• A Pilot Study of Immunization With HIV-1 Antigen Pulsed Allogenic Dendritic Cells in HIV-Infected Asymptomatic Patients With CD4+ T Cells > 350 Cells/mm3TerminatedNCT00001064Not applicable
• The Effectiveness of Three Drug Combinations in HIV-Infected Patients Who Have Taken Zidovudine for More Than 12 WeeksCompletedNCT00001063Phase 2
• A Study of Ganciclovir in the Treatment of Cytomegalovirus of the EyesCompletedNCT00001062Phase 1
• Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDSCompletedNCT00001061Phase 2
• A Phase I Trial of HIV-1 C4-V3 Polyvalent Peptide Vaccine in HIV-1 Infected PersonsCompletedNCT00001060Phase 1
• Comparison of Liposomal Doxorubicin Used Alone or in Combination With Bleomycin Plus Vincristine in the Treatment of Kaposi's Sarcoma in Patients With AIDSCompletedNCT00001059Phase 2
• A Comparison of Three Drug Combinations Containing Clarithromycin in the Treatment of Mycobacterium Avium Complex (MAC) Disease in Patients With AIDSCompletedNCT00001058Phase 2
• The Effectiveness of Two Anti-HIV Treatments in HIV-Infected PatientsCompletedNCT00001057Phase 2
• A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) of Human Immunodeficiency Virus: Evaluation of a 200-mcg DoseCompletedNCT00001056Phase 1
• A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) in HIV-1 Uninfected Adult VolunteersCompletedNCT00001055Phase 1
• The Safety and Effectiveness of Valacyclovir HCl in the Treatment of Herpes Simplex or Varicella/Zoster Infections in HIV-1 Infected ChildrenWithdrawnNCT00001054Phase 1
• A Phase I Safety and Immunogenicity Study of HIV p17/p24:Ty-VLP in HIV-1 Seronegative SubjectsCompletedNCT00001053Phase 1
• A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of MN Recombinant Soluble gp120/HIV-1 (rsgp120/HIV-1) (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy AdultsCompletedNCT00001052Phase 1
• Study of Women Who Have AIDSTerminatedNCT00001050
• A Study of Didanosine Use Alone or in Combination With Zidovudine in Infants Exposed to or Infected With HIVCompletedNCT00001049Phase 1
• Comparison of Anti HIV Drugs Used Alone or in Combination With Cytosine Arabinoside to Treat Progressive Multifocal Leukoencephalopathy (PML) in HIV-Infected PatientsCompletedNCT00001048Phase 2
• Study of Four Different Treatment Approaches for Patients Who Have Mycobacterium Avium Complex Disease (MAC) Plus AIDSCompletedNCT00001047Phase 3
• Active Immunization of HIV-Infected Pregnant Women: A Phase I Study of Safety and Immunogenicity of a rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)WithdrawnNCT00001046Phase 1
• Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients With No Symptoms of the DiseaseCompletedNCT00001045Phase 2
• A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of rgp120/HIV-1MN (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults.CompletedNCT00001044Phase 1
• A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination SchedulesCompletedNCT00001043Phase 1
• A Phase I, Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Compare the Safety and Immunogenicity of Recombinant Envelope Protein rgp120/HIV-1SF2 (BIOCINE) Combined With Seven Adjuvants in Healthy HIV-1 Uninfected IndividualsCompletedNCT00001042Phase 1
• Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)CompletedNCT00001041Phase 1
• Evaluation of Treatment for Mycobacterium Avium Complex (MAC) Infection in HIV-Infected PatientsCompletedNCT00001039Phase 2
• A Study of Valacyclovir Hydrochloride in the Prevention of Life-Threatening Cytomegalovirus Disease in HIV-Infected PatientsCompletedNCT00001038Phase 3
• A Phase I, Multicenter, Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination SchedulesCompletedNCT00001037Phase 1
• The Safety and Effectiveness of a Type of Interleukin-2 Plus Zidovudine Plus Thymosin in HIV-Positive Patients With and Without Symptoms of InfectionCompletedNCT00001036Phase 1
• The Safety and Effectiveness of a Two-Drug Combination in the Treatment of Patients With Hepatitis C Plus Advanced HIV InfectionsCompletedNCT00001035Phase 1
• The Safety and Effectiveness of Ganciclovir in the Prevention of Cytomegalovirus (CMV) of the Eyes and Disease of the Stomach and Intestines in Patients With HIVCompletedNCT00001034Phase 2
• The Treatment of Tuberculosis in HIV-Infected PatientsCompletedNCT00001033Phase 3
• A Study of Dideoxycytidine Plus Zidovudine (AZT) in HIV-Infected Children Who Have Taken AZTCompletedNCT00001032Phase 2
• A Phase II Clinical Trial to Evaluate the Immunogenicity and Reactogenicity of the Recombinant HIV-1 Envelope Vaccines SF-2 rgp120 (CHO) [Chiron Vaccines] in MF59 Adjuvant and MN rgp120/HIV-1 [VaxGen] in Alum Adjuvant in Healthy AdultsCompletedNCT00001031Phase 2
• The Safety and Effectiveness of Clarithromycin and Rifabutin Used Alone or in Combination to Prevent Mycobacterium Avium Complex (MAC) or Disseminated MAC Disease in HIV-Infected PatientsCompletedNCT00001030Phase 3
• A Comparison of Three Treatments for Advanced HIV Disease in Patients Who Have Received Nucleoside Therapy in the PastCompletedNCT00001029Phase 2
• A Study of Pentamidine Plus Dapsone in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Patients Who Cannot Take Trimethoprim or SulfonamidesCompletedNCT00001028Phase 3
• A Study of Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Children Who Cannot Take Trimethoprim-SulfamethoxazoleCompletedNCT00001027Phase 1
• A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV Envelope Vaccine (HIVAC-1e) in Combination With a Panel of Subunit Recombinant HIV Envelope Vaccines in Vaccinia-Naive IndividualsCompletedNCT00001026Phase 1
• Evaluation of Patients Who Have Not Had Success With ZidovudineCompletedNCT00001025Phase 2
• The Effects of Anti-HIV Drugs in HIV-Infected Patients Who Do Not Have AIDSCompletedNCT00001024Not applicable
• The Safety and Effectiveness of Rifabutin, Combined With Clarithromycin or Azithromycin, in HIV-Infected PatientsCompletedNCT00001023Not applicable
• A Comparison of Zidovudine (AZT) Used Alone or in Combination With Didanosine (ddI) or Dideoxycytidine (ddC) in HIV-Infected PatientsCompletedNCT00001022Phase 3
• A Phase I Multicenter Study of the Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine Given Either Alone or in Combination With IIIB rgp120/HIV-1 Vaccine in Healthy Adult Subjects (NOTE: Original Study Extended ONLY for Patients Previously Enrolled on VEU 009)CompletedNCT00001021Phase 1
• A Phase I Study of the Safety and Immunogenicity of rgp120/HIV-1IIIB Vaccine in Healthy Adult Subjects (NOTE: Study Extended ONLY for Subjects Who Have Previously Received rgp120/HIV-1IIIB or rgp120/HIV-1MN on VEU 006 or VEU 006 Rollover Study)CompletedNCT00001020Phase 1
• Safety of and Immune Response to an HIV Vaccine (SF-2 gp120) With or Without MTP-PE/MF59 AdjuvantCompletedNCT00001019Phase 1
• A Study of Letrazuril in the Treatment of AIDS-Related DiarrheaCompletedNCT00001018Phase 1
• A Treatment Protocol for the Use of Trimetrexate With Leucovorin Rescue for AIDS Patients With Pneumocystis Carinii Pneumonia and Serious Intolerance to Approved TherapiesCompletedNCT00001016Phase 3
• A Study of Ribavirin in the Treatment of Patients With AIDS and AIDS-Related ProblemsCompletedNCT00001015Phase 1
• Trimetrexate Plus Leucovorin Calcium Rescue Versus Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDSCompletedNCT00001014Phase 3
• Comparison of Trimetrexate Plus Leucovorin Calcium Rescue Versus Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDSCompletedNCT00001013Phase 3

← National Institutes of Health overview and focus areas